Professor Scientists oppose Ercüment Ovalı’s ‘drug’ declaration



[ad_1]

Professor who carries out projects with his team to develop vaccines and medicines against coronavirus. Dr. Ercüment Ovalı stated that a medication called “Dornaz alfa” is effective in treatment and stated that clinical trials should be started immediately. Reactions and objections came from scientists to Ovalı, who made a statement on Twitter.

Hematology professor, who made a statement on the subject from his Twitter account. Dr. Ovalı said: “We were going to announce the name of a drug that we have been working in the laboratory for 1 month on April 23, but it seems so effective that it can save people’s lives. We didn’t want to steal people’s days. Dornase alpha should be urgently brought to clinical trials in the treatment of patients. Thanks to my heroes. “

Ovalı’s exchange was received with messages of support from his followers on Twitter. Some followers also said that they should report such a statement to the Ministry of Health, rather than on Twitter. Appeals from the scientists also came to Ovalı’s explanation.

Professor at the Faculty of Medicine, Ankara University. Dr. In response to the message, Taner Demirer said that this drug has already been used in treatment with Covid-19.

Demirer said in his message: “Dornase alpha has been used in treatment with Kovid19 since March 27 in New Zealand and in many intensive care units. The article on this treatment was published in the Journal of Experimental Medicine on April 16, 2020. “

Neuroscience and genetics expert Assoc. Dr. Çağhan Kızıl said of Ovalı’s explanation: “The trafficking of hope is what happens in each period. It says, “Conduct clinical trials.” This is a drug that has already been used in the clinical trial for COVID in France. There are publications about it. Although what is studied in the laboratory is effective, it does not mean medicine. “

He has been carrying out a project at the National Center for Nanotechnology Research at Bilkent University (UNAM). Dr. Urartu Şeker said: “France began clinical studies on the related DNase enzyme on April 10, we hope that the” reused “drugs will be useful in overcoming the process, after the scientific processes.”

Dornase alpha is a medicine used to relieve the respiratory tract of patients with lung problems and to maintain lung function by reducing the frequency / severity of their infections.

[ad_2]